Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rocuronium and anaphylaxis--a statistical challenge.

J H Laake1, J A Røttingen

  • 1Department of Anaesthesiology, National Hospital (Rikshospitalet), Oslo, Norway. j.h.laake@basalmed.uio.no

Acta Anaesthesiologica Scandinavica
|December 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuromuscular blockade in patients with ARDS: a rapid practice guideline.

Intensive care medicine·2020
Same author

Intensive care doctors' preferences for arterial oxygen tension levels in mechanically ventilated patients.

Acta anaesthesiologica Scandinavica·2018
Same author

The SSAI fully supports the suspension of hydroxyethyl-starch solutions commissioned by the European Medicines Agency.

Acta anaesthesiologica Scandinavica·2018
Same author

Scandinavian SSAI clinical practice guideline on choice of inotropic agent for patients with acute circulatory failure.

Acta anaesthesiologica Scandinavica·2018
Same author

Emerging Salmonella Enteritidis anaerogenic phage type 14b: Outbreak in Norwegian, Swedish and Finnish travellers returning from Greece.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2017
Same author

CCCS-SSAI WikiRecs clinical practice guideline: vasopressor blood pressure targets in critically ill adults with hypotension and vasopressor use in early traumatic shock.

Intensive care medicine·2017

Drug-induced anaphylaxis from rocuronium bromide (Esmeron) is a concern. Norway reported more cases than other Nordic countries, highlighting surveillance challenges and statistical uncertainties in adverse drug reaction monitoring.

Area of Science:

  • Anesthesiology
  • Pharmacovigilance
  • Biostatistics

Background:

  • Drug-induced anaphylaxis is a significant concern in anesthesia, often linked to muscle relaxants.
  • Rocuronium bromide (Esmeron) use has been associated with frequent anaphylaxis reports in Norway.
  • Comparisons with other Nordic countries reveal significant discrepancies in reported anaphylaxis rates for rocuronium.

Purpose of the Study:

  • To analyze the reported rates of anaphylaxis associated with rocuronium bromide in Norway.
  • To highlight methodological issues in adverse drug reaction surveillance, including reporting bias and under-reporting.
  • To discuss the statistical challenges in estimating the true incidence of rare adverse events.

Main Methods:

  • Comparative analysis of anaphylaxis reports between Norway and other Nordic countries for rocuronium use.

Related Experiment Videos

  • Examination of data from approximately 150,000 patients in Norway and 800,000 in other Nordic countries.
  • Application of Poisson process principles to understand the statistical distribution of rare adverse events.

    • Main Results:

    • Norway reported 29 anaphylaxis cases among 150,000 patients receiving rocuronium.
    • Other Nordic countries reported only 7 cases among approximately 800,000 patients treated with rocuronium.
    • Significant disparities suggest potential issues with reporting culture and bias in pharmacovigilance.

    Conclusions:

    • Adverse drug reaction surveillance data requires careful interpretation due to potential biases and under-reporting.
    • The statistical nature of rare events, often following a Poisson distribution, necessitates understanding variability in estimates.
    • Anesthesiologists must be aware of these methodological and statistical challenges for informed decision-making regarding muscle relaxants.